Heidelberg Pharma AG (HPHA.DE)

EUR 2.38

(-0.42%)

Gross Profit Summary of Heidelberg Pharma AG

  • Heidelberg Pharma AG's latest annual gross profit in 2023 was 6.6 Million EUR , down -58.6% from previous year.
  • Heidelberg Pharma AG's latest quarterly gross profit in 2024 Q2 was 1.24 Million EUR , up 22.13% from previous quarter.
  • Heidelberg Pharma AG reported a annual gross profit of 13.83 Million EUR in annual gross profit 2022, up 567.03% from previous year.
  • Heidelberg Pharma AG reported a annual gross profit of -2.96 Million EUR in annual gross profit 2021, down -202.57% from previous year.
  • Heidelberg Pharma AG reported a quarterly gross profit of 1.24 Million EUR for 2024 Q2, up 22.13% from previous quarter.
  • Heidelberg Pharma AG reported a quarterly gross profit of 1.05 Million EUR for 2024 Q3, down -15.56% from previous quarter.

Annual Gross Profit Chart of Heidelberg Pharma AG (2023 - 2006)

Historical Annual Gross Profit of Heidelberg Pharma AG (2023 - 2006)

Year Gross Profit Gross Profit Growth
2023 6.6 Million EUR -58.6%
2022 13.83 Million EUR 567.03%
2021 -2.96 Million EUR -202.57%
2020 2.88 Million EUR -19.11%
2019 3.57 Million EUR 144.56%
2018 1.45 Million EUR 54.76%
2017 943.34 Thousand EUR 70.61%
2016 552.93 Thousand EUR -51.67%
2015 1.14 Million EUR -48.98%
2014 2.24 Million EUR -76.74%
2013 9.63 Million EUR -13.12%
2012 11.09 Million EUR 94.23%
2011 5.71 Million EUR 0.0%
2010 - EUR -100.0%
2009 10 Million EUR 0.0%
2008 - EUR 0.0%
2007 - EUR 0.0%
2006 - EUR 0.0%

Peer Gross Profit Comparison of Heidelberg Pharma AG

Name Gross Profit Gross Profit Difference
BioNTech SE 3.21 Billion EUR 99.795%
CureVac N.V. -70.6 Million EUR 109.356%
Biotest Aktiengesellschaft 271.9 Million EUR 97.57%
Biotest Aktiengesellschaft 271.9 Million EUR 97.57%
BRAIN Biotech AG 30.12 Million EUR 78.069%
Formycon AG 23.3 Million EUR 71.654%
Medigene AG 4.39 Million EUR -50.446%